A new method of monitoring osteomyelitis

International Journal of Oral and Maxillofacial Surgery

Volumn 36, Issue 6, 2007, Pages 527-532

  Springer, I N G ^a   Wiltfang, J ^a   Dunsche, A ^b   Lier, G C ^a   Bartsch, M ^a   Warnke, P H ^a   Barth, E L ^c   Terheyden, H ^a   Russo, Paul A J ^d   Czech, N ^a   Acil, Y ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b Klinikum Karlsruhe   (Germany)

^c LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

bone; hydroxylysylpyridinoline; lysylpyridinoline; marker; monitoring; osteomyelitis

Indexed keywords

BIOCHEMICAL MARKER; DEOXYPYRIDINOLINE; MEDRONATE TECHNETIUM TC 99M; PYRIDINOLINE;

ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEBRIDEMENT; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FLUORESCENCE ANALYSIS; HEALTH CARE COST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MANDIBLE RESECTION; OSTEOMYELITIS; PANORAMIC RADIOGRAPHY; PATIENT MONITORING; PREDICTION; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEST RETEST RELIABILITY; TREATMENT OUTCOME; URINALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACIDS; BIOLOGICAL MARKERS; CHROMATOGRAPHY; EPIDEMIOLOGIC METHODS; FEMALE; FLUORESCENCE; HUMANS; MALE; MANDIBULAR DISEASES; MIDDLE AGED; OSTEOMYELITIS; RECURRENCE; SEX FACTORS;

EID: 34248224628     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2007.01.001     Document Type: Article

References (37)

1. Acil Y., and Müller P.K. A rapid method for the isolation of the mature collagen cross-links, hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP). J Chromatogr A 664 (1994) 183-188
2. Acil Y., Vetter U., Brenner R., Muller P.K., and Brinckmann J. Ehlers-Danlos syndrome type VI: cross-link pattern in tissue and urine sample as a diagnostic marker. J Am Acad Dermatol 33 (1995) 522-524
3. Acil Y., Brinckmann J., Notbohm H., Muller P.K., and Batge B. Changes with age in the urinary excretion of hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP). Scand J Clin Lab Invest 56 (1996) 275-283
4. Acil Y., Springer I.N.G., Prasse J.G., Hedderich J., and Jepsen S. Concentration of collagen cross-links in human dentin bears no relation to the individual age. Int J Legal Med 116 (2002) 340-343
5. Bhatti M.A., and Seville M.T. Images in clinical medicine. Hematogenous anaerobic osteomyelitis. N Engl J Med 346 (2002) 1060
6. Bombardieri E., Aktolun C., Baum R.P., Bishof-Delaloye A., Buscombe J., Chatal J.F., Maffioli L., Moncayo R., Morteimans L., and Reske S.N. Bone scintigraphy: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging 30 (2003) BP99-BP106
7. Branca F., Robins S.P., Ferro-Luzzi A., and Golden M.H. Bone turnover in malnourished children. Lancet 340 (1992) 1493-1496
8. Chen J.T., Hosoda K., Hasumi K., Ogata E., and Shiraki M. Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women. J Bone Miner Res 11 (1996) 1784-1792
9. Coleman R.E., Purohit O.P., Black C., Vinholes J.J., Schlosser K., Huss H., Quinn K.J., and Kanis J. Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease. Ann Oncol 10 (1999) 311-316
10. Eckman M.H., Greenfield S., Mackey W.C., Wong J.B., Kaplan S., Sullivan L., Dukes K., and Pauker S.G. Foot infections in diabetic patients. Decision and cost-effectiveness analyses. JAMA 273 (1995) 712-720
11. Eyre D. New biomarkers of bone resorption. J Clin Endocrinol Metab 74 (1992) 470A-1470A
12. Fogelman I., Bessent R.G., Turner J.G., Citrin D.L., Boyle I.T., and Greig W.R. The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease. J Nucl Med 19 (1978) 270-275
13. Giannobile W.V., Lynch S.E., Denmark R.G., Paquette D.W., Fiorellini J.P., and Williams R.C. Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis. A pilot study in beagle dogs. J Clin Periodontol 22 (1995) 903-910
14. Giannobile W.V. C-telopeptide pyridinoline cross-links. Sensitive indicators of periodontal tissue destruction. Ann N Y Acad Sci 878 (1999) 404-412
15. Grayson M.L., Gibbons G.W., Balogh K., Levin E., and Karchmer A.W. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA 273 (1995) 721-723
16. Grime P.D., Bowerman J.E., and Weller P.J. Gentamicin impregnated polymethylmethacrylate (PMMA) beads in the treatment of primary chronic osteomyelitis of the mandible. Br J Oral Maxillofac Surg 28 (1990) 367-374
17. Hino S., Murase R., Terakado N., Shintani S., and Hamakawa H. Response of diffuse sclerosing osteomyelitis of the mandible to alendronate: follow-up study by 99mTc scintigraphy. Int J Oral Maxillofac Surg 34 (2005) 576-578
18. Holmes R.A. Quantification of skeletal Tc-99m labeled phosphates to defect metabolic bone disease. J Nucl Med 19 (1978) 330-331
19. Hoskin P.J., Stratford M.R., Folkes L.K., Regan J., and Yarnold J.R. Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity. Lancet 355 (2000) 1428-1429
20. Hudson J.W. Osteomyelitis of the jaws: a 50-year perspective. J Oral Maxillofac Surg 51 (1993) 1294-1301
21. Jepsen S., Springer I.N.G., Buschmann A., Hedderich J., and Acil Y. Elevated levels of collagen cross-link residues in gingival tissues and crevicular fluid of teeth with periodontal disease. Eur J Oral Sci 111 (2003) 198-202
22. Körner T., Kreusch T., Bohuslavizki K.H., Brinkmann G., and Kohnlein S. Magnetic resonance imaging vs. three-dimensional scintigraphy in the diagnosis and monitoring of mandibular osteomyelitis. Mund Kiefer Gesichtschir 1 (1997) 324-327
23. Martin-de las Heras S., Valenzuela A., and Villanueva E. Deoxypyridinoline crosslinks in human dentin and estimation of age. Int J Legal Med 112 (1999) 222-226
24. Ogawa A., Miyate H., Nakamura Y., Shimada M., Seki S., and Kudo K. Treating chronic diffuse sclerosing osteomyelitis of the mandible with saucerization and autogenous bone grafting. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 (2001) 390-394
25. Reichart P.A., and Philipsen H.P. Osteomyelitis. In: Rateitschak K.H., and Wolf H.F. (Eds). Oralpathologie (1999), Thieme, Stuttgart 191-195
26. Reinert S., Widlitzek H., and Venderink D.J. The value of magnetic resonance imaging in the diagnosis of mandibular osteomyelitis. Br J Oral Maxillofac Surg 37 (1999) 459-463
27. Risteli J., Elomaa I., Niemi S., Novamo A., and Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 39 (1993) 635-640
28. Springer I.N., Terheyden H., Suhr M.A., Warnke P., Dunsche A., Tiemann M., and Acil Y. Follow-up of collagen crosslink excretion in patients with oral squamous cell carcinoma and analysis of tissue samples. Br J Cancer 89 (2003) 1722-1728
29. Springer I.N., Acil Y., Kuchenbecker S., Bolte H., Warnke P.H., Abboud M., Wiltfang J., and Terheyden H. Bone graft versus BMP-7 in a critical size defect-cranioplasty in a growing infant model. Bone 37 (2005) 563-569
30. Springer I.N.G., Suhr M., and Fleiner B. Adaptive adjustment of the adolescent porcine mandibular condyle. Bone 31 (2002) 1190-1195
31. Springer I.N.G., Terheyden H., Dunsche A., Czech N., Tiemann M., Hedderich J., and Açil Y. Collagen crosslink excretion and staging of oral cancer. Br J Cancer 88 (2003) 1105-1110
32. Wannfors K., and Hansson L.O. Plasma protein changes in chronic osteomyelitis of the jaws. J Oral Pathol Med 20 (1991) 81-85
33. Warnke P.H., Springer I.N., Wiltfang J., Acil Y., Eufinger H., Wehmöller M., Russo P.A.J., Bolte H., Sherry E., Behrens E., and Terheyden H. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 364 (2004) 766-770
34. Warnke P.H., Springer I.N., Russo P.A., Wiltfang J., Essig H., Kosmahl M., Sherry E., and Acil Y. Innate immunity in human bone. Bone 38 (2005) 400-408
35. Wiltfang J., and Merten H.A. Ectopic bone formation with the help of growth factor bFGF. J Craniomaxillofac Surg 24 (1996) 300-304
36. Woitge H.W., Pecherstorfer M., Li Y., Keck A.V., Horn E., Ziegler R., and Seibel M.J. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices. J Bone Miner Res 14 (1999) 792-801
37. Zegels B., Eastell R., Russell R.G., Ethgen D., Roumagnac I., Collette J., and Reginster J.Y. Effect of high doses of oral risedronate (20 mg/day) on serum parathyroid hormone levels and urinary collagen cross-link excretion in postmenopausal women with spinal osteoporosis. Bone 28 (2001) 108-112